PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV

NCT04084626 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing Friendship Hospital